Skip to main content
Signal8

Parsons James T.

SEC insider (Form 3/4/5 filer). CIK 0001759855. Director at DiaMedica Therapeutics Inc. (DMAC) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in SAN DIEGO, CA.

Companies Parsons James T. has filed insider reports for

  • DiaMedica Therapeutics Inc. (DMAC): Director
  • ONCOLYTICS BIOTECH INC (ONCY): Director
Parsons James T. profile photo

Parsons James T.

CIK: 0001759855

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

DiaMedica Therapeutics Inc. logo
DMAC

DiaMedica Therapeutics Inc.

Director
ONCOLYTICS BIOTECH INC logo
ONCY

ONCOLYTICS BIOTECH INC

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Jun 1, 2026
    Award

    Stock Option (right to buy)

    Direct
    51.2K shares-
  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Jun 1, 2026
    Award

    Stock Option

    Direct
    30K shares-
  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Mar 11, 2026
    Purchase
    Direct
    10K shares at avg. $1.03$10K
  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Jan 2, 2026
    Award
    Direct
    10.1K shares at avg. $8.42$85K
  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Nov 21, 2025
    Exercise
    Direct
    12K shares at avg. $2.20$26K
  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Jun 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    40.7K shares-
  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Jan 2, 2025
    Award
    Direct
    15.9K shares at avg. $5.34$85K

1-7 of 7